dc.contributor.author | Ayala, Alba | |
dc.contributor.author | Triviño Juárez, José Matías | |
dc.contributor.author | Forjaz, María Joao | |
dc.contributor.author | Rodríguez Blázquez, Carmen | |
dc.contributor.author | Rojo Abuin, José Manuel | |
dc.contributor.author | Martínez Martín, Pablo | |
dc.contributor.author | Cubo Delgado, Esther | |
dc.contributor.author | ELEP Group | |
dc.date.accessioned | 2024-03-08T08:57:26Z | |
dc.date.available | 2024-03-08T08:57:26Z | |
dc.date.issued | 2017-10 | |
dc.identifier.uri | http://hdl.handle.net/10259/8780 | |
dc.description.abstract | Objective: The aim of this study is to present a predictive model of Parkinson’s disease (PD) global severity, measured with the Clinical Impression of Severity Index for Parkinson’s Disease (CISI-PD). Methods: This is an observational, longitudinal study with annual follow-up assessments over 3 years (four time points). A multilevel analysis and multiple imputation techniques were performed to generate a predictive model that estimates changes in the CISI-PD at 1, 2, and 3 years. Results: The clinical state of patients (CISI-PD) significantly worsened in the 3-year follow-up. However, this change was of small magnitude (effect size: 0.44). The following baseline variables were significant predictors of the global severity change: baseline global severity of disease, levodopa equivalent dose, depression and anxiety symptoms, autonomic dysfunction, and cognitive state. The goodness-of-fit of the model was adequate, and the sensitive analysis showed that the data imputation method applied was suitable. Conclusion: Disease progression depends more on the individual’s baseline characteristics than on the 3-year time period. Results may contribute to a better understanding of the evolution of PD including the non-motor manifestations of the disease. | en |
dc.description.sponsorship | The Spanish Longitudinal PD Patient Study (Estudio longitudinal de pacientes con enfermedad de Parkinson) was supported by an Intramural Research Programme grant from the Carlos III Institute of Health (Code: EPY1271/05). Partial funding was also obtained from the following grants: ENVACES (MINECO/FEDER/UE, ref. CSO2015-64115-R) and ENCAGE-CM (Comunidad de Madrid, ref. S2015/HUM-3367). | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | es |
dc.publisher | Frontiers Media | en |
dc.relation.ispartof | Frontiers in Neurology. 2017, V. 8 | en |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Parkinson’s disease | en |
dc.subject | Disease global severity | en |
dc.subject | Predictive model | en |
dc.subject | Multilevel analysis | en |
dc.subject | Multiple imputation | en |
dc.subject.other | Sistema nervioso-Enfermedades | es |
dc.subject.other | Nervous system-Diseases | en |
dc.subject.other | Neurología | es |
dc.subject.other | Neurology | en |
dc.subject.other | Medicina | es |
dc.subject.other | Medicine | en |
dc.title | Parkinson’s Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline | en |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.relation.publisherversion | https://doi.org/10.3389/fneur.2017.00551 | es |
dc.identifier.doi | 10.3389/fneur.2017.00551 | |
dc.identifier.essn | 1664-2295 | |
dc.journal.title | Frontiers in Neurology | en |
dc.volume.number | 8 | es |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
Browse
All of RIUBUCommunities and CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects